Author:
Brennan Brian P,Hudson James I,Jensen J Eric,McCarthy Julie,Roberts Jacqueline L,Prescot Andrew P,Cohen Bruce M,Pope Harrison G,Renshaw Perry F,Öngür Dost
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference64 articles.
1. Banasr M, Chowdhury GM, Terwilliger R, Newton SS, Duman RS, Behar KL et al (2008). Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry (e-pub ahead of print 30 September).
2. Batra NA, Seres-Mailo J, Hanstock C, Seres P, Khudabux J, Bellavance F et al (2008). Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. Biol Psychiatry 63: 1178–1184.
3. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Ashworth F, Sule A et al (2007). Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry 61: 806–812.
4. Cecil KM, DelBello MP, Morey R, Strakowski SM (2002). Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 4: 357–365.
5. Cheramy A, Barbeito L, Godeheu G, Glowinski J (1992). Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo. Neurosci Lett 147: 209–212.
Cited by
149 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献